Synaptiflora
AI-Powered Microbiome Intelligence Suite for Precision Drug Development
StartupSynaptiflora is a Haifa-based startup in the Health Tech & Life Sciences sector, established in 2024. AI-Powered Microbiome Intelligence Suite for Precision Drug Development. The company has raised a total of $10K across 1 funding round, currently at the Pre-Funding stage. Synaptiflora was founded by Shaul Sapielkin. The company has 1-10 employees. Core technologies: Artificial Intelligence, Generative AI, Deep Learning, Machine Learning.
With $10K in total funding, Synaptiflora is a Pre-Funding-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: R&D.
- StagePre-Funding
- ProductR&D
- ModelB2B
- Employees1-10
- HQHaifa
- DistrictNorth District
- Last Round$10K
Shaul SapielkinCTO
What does Synaptiflora do?
Synaptiflora offers an AI-driven microbiome analytics platform aimed at accelerating drug development. The system integrates microbiome composition, metabolomics, and host data via a foundational AI model—SynaptiCore—enabling disease-specific modules for applications like trial optimization and biomarker discovery By translating complex biological data into actionable insights, the platform helps pharmaceutical companies predict patient response, improve stratification, and reduce trial failures. Synaptiflora focuses on oncology and immunology use cases, built from a proprietary microbiome dataset and validated through a proof-of-concept for colorectal cancer with around 90% accuracy in predicting non-responders—claiming the ability to accelerate trials and increase drug efficacy.
How much funding has Synaptiflora raised?
Synaptiflora has raised $10K in total funding across 1 rounds. The company is currently at the Pre-Funding stage.
Who founded Synaptiflora?
Synaptiflora was founded in 2024 by Shaul Sapielkin (CTO).
What sector is Synaptiflora in?
Synaptiflora operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, Digital Healthcare, Clinical Workflow, with core technologies in Artificial Intelligence, Generative AI, Deep Learning, Machine Learning. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals, Biotechnology.
Where is Synaptiflora located?
Synaptiflora is based in Haifa, Israel, North District.